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Sex myoblastFGF receptor, EGL-15, is alternatively-spliced to yield two major isoforms that
differ in their extracellular domains. The EGL-15(5A) isoform is necessary for the gonadal chemoattraction of
the migrating sex myoblasts (SMs), while the EGL-15(5B) isoform is required for viability. Here we show that
5A is predominantly expressed in the M lineage, which gives rise to the migrating SMs and their sex muscle
descendants, while 5B is predominantly expressed in the hypodermis. Tissue-speciﬁc expression, however,
explains only part of the functional differences between these two receptor isoforms. 5A can carry out the
reciprocal essential function of 5B when expressed in the hypodermis, but 5B is incapable of carrying out SM
chemoattraction. Our data, therefore, indicate that the structural differences in these two isoforms contribute
to their functional differences. Two lines of evidence indicate that the 5B isoform also plays a role in SM
migration, implicating it in the repulsion that is observed when the chemoattraction is compromised. Thus,
structural differences in the extracellular domains of these two isoforms can specify either attraction to or
repulsion from the gonad.
© 2008 Elsevier Inc. All rights reserved.IntroductionDuring metazoan development, cells acquire functional positions
either as a natural consequence of their birth position or by cell
migration. The cells thatmigrate are often guided along their routes by
attractive and/or repulsive cues, many of which also serve to guide
axon outgrowth (Bagri and Tessier-Lavigne, 2002). Although their
paths can be quite intricate, there is a relatively small set of molecules
that serve as these cues, including growth factors, netrins, ephrins and
semaphorins. Interestingly, many of these components can function
either in attraction or repulsion (Bagri and Tessier-Lavigne, 2002).
In Caenorhabditis elegans hermaphrodites, themigrations of the sex
myoblasts (SMs) are also controlled by both attractive and repulsive
mechanisms (Stern and Horvitz, 1991; Thomas et al., 1990). The SMsrn).
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l rights reserved.are a pair of bilaterally symmetric cells that are born in the posterior of
the animal. After their birth, the SMs undergo anteriorly-directed
migrations toﬂank the precise center of the developing gonad (Sulston
andHorvitz,1977); subsequently, they divide and differentiate into the
muscles required for egg laying. A variety of mechanisms control sex
myoblast migration (Branda and Stern, 2000; Chen and Stern, 1998).
The mechanism responsible for their precise positioning is a gonad-
dependent attraction (GDA), in which the ﬁbroblast growth factor
(FGF) chemoattractant, EGL-17, guides the SMs toward the center of the
gonad (Branda and Stern, 2000). Mutations that eliminate EGL-17 do
not merely disrupt the GDA, but also result in a gonad-dependent
repulsion (GDR) of the SMs (Stern andHorvitz,1991). A speciﬁc class of
mutations affecting the C. elegans FGF receptor (FGFR), EGL-15, behave
similarly (Goodman et al., 2003). These mutations suggest that, in
addition to a chemoattractive mechanism, there is also a repulsive
mechanism that is revealed when the chemoattraction is no longer
operational. SM migration can also occur in the absence of all gonadal
cues. In the absence of the GDA and the GDR, the gonad-independent
mechanism allows the SMs to migrate anteriorly and assume a broad
distribution of ﬁnal positions just posterior to the center of the gonad
(Thomas et al., 1990; Branda and Stern, 2000).
Sex myoblasts also respond to dorsal–ventral signals that help to
conﬁne the SMs to the ventral side of the animal (Branda and Stern,
2000). Both the EGL-17 chemoattractant and the C. elegans round-
about (ROBO) orthologue, SAX-3 (Hao et al., 2001), maintain the SMs
ventrally (Branda and Stern, 2000). The normal chemoattractive
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SMs from wandering dorsally. However, even in the absence of SM
chemoattraction, the SMs aremaintained ventrally by the action of the
SAX-3 receptor, which presumably enables dorsal sources of its ligand,
SLIT, to keep the SMs in ventral positions.
In addition to SM migration, EGL-15 plays a role in numerous
processes, including an essential, ﬂuid homeostasis function. EGL-15
regulates ﬂuid homeostasis by acting in the hypodermis (Huang and
Stern, 2004), activating well-characterized signal transduction path-
ways (Borland et al., 2001). Several phenotypes have been associated
with this role of EGL-15: hyperactivity of EGL-15 results in a Clear (Clr)
phenotype (Kokel et al., 1998), while complete loss of function of EGL-
15, or the LET-756 FGF ligand, results in an early larval arrest (DeVore
et al., 1995; Roubin et al., 1999).
The domain architecture of EGL-15 resembles other FGFRs, but it
also has some unique features as well. Similar to mammalian FGF
receptors, EGL-15 has three extracellular Ig domains, an acid box, and
an intracellular tyrosine kinase domain. Unique to EGL-15, however, is
a small peptide insert that lies between the ﬁrst Ig domain and the
acid box, termed the EGL-15-speciﬁc insert (Goodman et al., 2003).
Alternative splicing of the EGL-15-speciﬁc insert leads to two receptor
isoforms, EGL-15(5A) and EGL-15(5B). The different EGL-15(5A) and
EGL-15(5B) isoforms, along with their ligands, EGL-17 and LET-756,
carry out different functions (Bulow et al., 2004; Goodman et al., 2003;
Huang and Stern, 2004; Kuroyanagi et al., 2006). EGL-15(5B) is
required for the essential function of EGL-15, while EGL-15(5A) is
required for SM chemoattraction.
While the role of the 5A isoform in SM chemoattraction is clear, here
we further investigate the broad role of EGL-15 in SM migration.
Hypomorphic mutations that affect both EGL-15 isoforms have complex
effects on SM positioning, suggesting the possibility that EGL-15 is
involved in not only the GDA, but possibly also in other SM migration
mechanisms as well. Here we investigate the basis of the speciﬁcity of
the 5A isoform for SM chemoattraction and the 5B isoform for ﬂuid
homeostasis. In addition, we show that EGL-15 is involved in both the
attractive and repulsive mechanisms that guide the migrating SMs.
Materials and methods
Genetic and transgenic manipulations
All strains were derived from C. elegans var. Bristol, strain N2 using standard genetic
protocols and standard genetic manipulations (Brenner, 1974; Herman, 1988). Transgenic
arrays were generated using standard germline transformation techniques (Mello et al.,
1991). Rescue assays and SM scoring were performed as described (Goodman et al.,
2003). Laser microsurgery was used to ablate the precursor cells of the somatic gonad
(Z1 and Z4) in newly-hatched L1 animals as previously described (Thomas et al., 1990).
Determination of sex myoblast positions
The ﬁnal positions of sex myoblasts were determined with respect to the
underlying hypodermal Pn.p cells as previously described (Thomas et al., 1990;
Goodman et al., 2003). SM distributions for each strain are depicted using box-and-
whisker plots (Moore and McCabe, 1993) aligned to a schematic representation of the
Pn.p cell metric. This representation of SMs depicts the overall range of SMs as well as
their general distribution and median position. Brieﬂy, each set of SMs is ordered
according to anteroposterior position and divided into quartiles. The “box” includes the
positions of SMs within the two central quartiles. An additional vertical line within the
box indicates themedian SM position. A quartile length (1Q) is determined based on the
range of positions covered by the 2Q box length. Bars (“whiskers”) of up to 1.5Q length
extend from the edges of the box to additional data points. As whisker length does not
extend beyond the range of data points, these barsmay be shorter than a 1.5 Q length, or
even absent. Data points beyond the edge of the bars (“outliers”) are indicated by
individual hash marks.
Plasmid construction
NH#112 [egl-15(A+B+)] contains the wild-type egl-15 genomic rescuing fragment.
NH#872 [egl-15(A−B+)] and NH#873 [egl−15(A+B−)] are NH#112 derivatives that eliminate
the normal expression of either the EGL-15(5A) or the EGL-15(5B) isoform, respectively,
without altering the expression pattern of the non-mutated isoform (Goodman et al.,
2003). NH#1130 [egl-15(Δ5)] is another NH#112 derivative in which exon 4 was fused
directly to exon 6, thereby eliminating the EGL-15-speciﬁc insert from both extracellularisoforms. NH#1159 [egl-15(4A6)] was generated from NH#112 by replacing genomic DNA
spanning from exon 4 through exon 6 with the corresponding exon 5A-containing cDNA,
thereby forcing expression of the 5A transcript at all sites of egl-15 transcription. NH#1160
[egl-15(4B6)] was generated similarly to NH#1159 using an exon 5B-containing cDNA,
thereby forcing the expression of the 5B transcript at all sites of egl-15 transcription.
NH#1173, Prol-6::egl-15, fuses the rol-6 promoter region (from −976 to −1) to the genomic
coding sequence of egl-15 at an inserted NcoI site overlapping the initiating ATGs of rol-6
and egl-15. All PCR-derived fragments were conﬁrmed by sequencing. A summary table of
plasmids and alleles described in this work and further details of their construction can be
found in the online supplementary material.
Transgenes
Transgenic rescue assays were performed as described (Goodman et al., 2003).
Transgenes that have the normal expression pattern for only one of the two EGL-15
isoforms contained egl-15 constructs in which nonsense mutations speciﬁcally
eliminate one of the two isoforms (Goodman et al., 2003). The sites of observable
EGL-15 expression from these arrays are likely to reﬂect the endogenous expression
pattern, since the arrays rescue the corresponding speciﬁc EGL-15 function (Goodman
et al., 2003). ayIs6[Ptwist ::GFP] animals express GFP in all the undifferentiated cells in the
M lineage (Harfe et al., 1998). ayIs29[egl-15(WT)] was isolated as a spontaneous
integrant of an extrachromosomal array carrying thewild-type egl-15 genomic rescuing
fragment, NH#112 (5 ng/μl), the Pmyo-2::GFP transformation marker, pJKL449.1 (5 ng/μl),
and pGEM-5Z (70 ng/μl). All other integrated arrays were isolated using a standard UV-
TMP protocol (Huang, 2004). ayIs39[egl-15(A−B+)] and ayIs40[egl-15(A+B−)] are inte-
grated arrays that were isolated from extrachromosomal arrays generated with the
same mixture of DNAs, using NH#872 or NH#873, respectively, as the source of egl-15
DNA. Extrachromosomal arrays that alter the normal expression pattern for the two
EGL-15 isoforms, 4A6 (NH#1159) and 4B6 (NH#1160), as well as the extrachromosomal
arrays containing the egl-15 construct that lacked both the 5A and 5B domains, Δ5
(NH#1130), were injected using the same concentrations of egl-15 DNA, the
transformation marker, and pGEM-5Z. ayIs30-ayIs33 and ayIs36 are integrated arrays
carrying the Prol-6 ::egl-15 plasmid (NH#1173, 5 ng/μl), the Pmyo-2::GFP transformation
marker (pJKL449.1, 5 ng/μl) and sheared genomic DNA (50 ng/μl).
Mosaic analysis
The ayEx86 array used for the mosaic analysis contained NH#112 [egl-15(+), 75 ng/
μl], c33C3 [ncl-1(+), 150 ng/μl], and col-19∷GFP [50 ng/μl]. This array rescues the Ncl
phenotype of ncl-1(e1865) mutants such that cells carrying the array are easily
distinguishable from those that have lost it (Hedgecock and Herman, 1995; see Suppl.
Material for a list of cells scored). This array also rescues the SMmigration defects of egl-
15 mutants. egl-15(n1458) (A−B+) or egl-15(n1456) (A−B−) mutant animals carrying this
array appear wild type and have correctly positioned SMs; progeny which have lost the
array in the P0 zygote have either posteriorly-positioned SMs or an L1 larval arrest
phenotype, respectively. col-19∷GFP served as the co-injection marker and is expressed
in adult hypodermal cells.
Immunohistochemistry
Animals were synchronized in early L1 by hatching in the absence of food and then
grown to the appropriate developmental stage by culturing on seeded plates at 15 °C.
Developmental stage was conﬁrmed by examining Ptwist ::GFP expression in the M
lineage as well as other landmarks such as the divisions of the intestinal nuclei and the
extent of gonadal development. Animals were harvested and stained following a
protocol modiﬁed from Finney and Ruvkun (1990). Two afﬁnity puriﬁed α-EGL-15
primary antibodies (Pop, which recognizes the acid box, and Crackle, which recognizes
the carboxy-terminal domain) were used at a 1:10 dilution; Alexa Fluor 546-conjugated
anti-rabbit antibody (Molecular Probes) was used as a secondary antibody at a 1:250
dilution. Double-staining experiments were performed by following the above
protocol, applying the α-EGL-15 primary antibody, the Alexa Fluor 546-conjugated
anti-rabbit antibody, and then repeating the staining protocol using an α-GFP
monoclonal antibody (JL-8, Clontech) at a 1:10 dilution, and a goat α-mouse FITC-
conjugated secondary antibody (Jackson ImmunoLab) at a 1:50 dilution.
Photomicroscopy
All photomicrographs were collected using a Hamamatsu C4742-95 digital camera
mounted on a Zeiss Axioskopmicroscope that contains an internal 0.63× reduction lens.
Images were collected as a z-series of 0.5 μm sections, merged into a single composite
image, and false colored using OpenLab software. Images were then cropped and scaled
using Adobe Photoshop.
Results
In vivo distribution of EGL-15
It was important to establish the sites of expression of the two
major isoforms of EGL-15 in order to understand the basis of the
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functions, and to determine whether EGL-15 affects SM migration
mechanisms beyond the requirement of the 5A isoform for SM
chemoattraction. Previous analyses revealed that egl-15 is expressed
both in the hypodermis (Bulow et al., 2004; Huang and Stern, 2004)
and in the early M lineage and SM-derived vulval muscles (Harfe et al.,
1998; Sasson and Stern, 2004). In addition, it was recently shown that
alternative splicing is responsible for a bias of expression of the egl-15
(5A) transcript in vulval and body wall muscles and egl-15(5B) in the
hypodermis (Kuroyanagi et al., 2006). However, expression of EGL-15
has only rarely been observed in the SMs (Burdine et al., 1998) and
never in the SMs at the time of their migration, the crucial time for
EGL-15 to control SM migration guidance.
To establish the sites of expression of the twomajor isoforms of EGL-
15, α-EGL-15 antibodies were used in a series of systematic immuno-
ﬂuorescence studies. Since endogenous levels of EGL-15 are below the
threshold of detection, we performed these studies on strains that
express increased levels of EGL-15 under the control of its ownpromoter
from integrated transgenic arrays. These arrays can rescue the appro-
priate functions of EGL-15 and do not cause any observable phenotypes
characteristic of gross over-expression. ayIs29 [egl-15(A+B+)] contains the
wild-type egl-15 genomic rescuing fragment and expresses both
isoforms of EGL-15. Similar arrays express either the EGL-15(5A) isoform
(ayIs40) or the EGL-15(5B) isoform (ayIs39). To aid in the identiﬁcation of
M-derived cells, these strains also contain the reporter construct ayIs6
[Phlh-8::GFP] (Harfe et al., 1998).
Examination of ayIs29; ayIs6 animals at various developmental
stages revealed that EGL-15 is expressed in both the hypodermis and
in portions of the M lineage, consistent with what has previously been
reported (Figs. 1A, D, G) (Bulow et al., 2004; Huang and Stern, 2004;
Sasson and Stern, 2004). However, expression of EGL-15 within the
SM during the time of its migration (early L2 stage) remained difﬁcult
to observe. To understand the speciﬁc requirement for each of the
EGL-15 isoforms better, we looked at the tissue-speciﬁc distribution of
each of the isoforms using α-EGL-15 antibodies and the arrays
described above designed to express only one of the two EGL-15
isoforms. These studies revealed that expression of the 5A isoform is
predominantly localized to the M lineage, while the hypodermis is theFig. 1. EGL-15 isoform-speciﬁc expression patterns. EGL-15(5B) is primarily expressed in the
(WT)]; ayIs6, (B,E,H) ayIs40[egl-15(5A+B−)]; ayIs6, and (C,F,I) ayIs39[egl-15(5A−B+)]; ayIs6 anim
undifferentiated cells in the M lineage. (A–C) α-EGL-15 staining in the hypodermis of L1 anim
cells, with increased staining intensity at the hyp-seam cell junction. In the absence of tran
migrating sexmyoblast at the end of the L1 stage. EGL-15 is expressed in the GFP+ SM. In the a
the undivided SM at the L3 stage. All animals are oriented anterior left and ventral down. Rmajor site of EGL-15(5B) expression (Fig. 1). Moreover, expression
analysis of these isoforms across development revealed that 5A is
present in the M lineage at all stages (Fig. S1). These data suggest that
the tissue-speciﬁc expression patterns for the 5A and 5B isoforms may
be important in specifying the speciﬁc functions of EGL-15.
The 5A speciﬁc insert is unique in its ability to mediate SM
chemoattraction
Previous isoform-speciﬁc constructs (NH#872, NH#873) elimi-
nated either the 5A or the 5B isoforms from the wild-type egl-15
rescuing fragment, but did not alter the normal expression pattern for
the remaining isoform (Goodman et al., 2003). Thus, those constructs
tested which EGL-15 functions could be performed by the normal
expression pattern of the remaining isoform. To test whether
structural differences in the two isoforms also speciﬁed their
functions, we tested whether individual isoforms could carry out
each EGL-15 function if expressed in the cellular site of action
corresponding to that function. In other words, we wanted to test
whether driving expression of the 5A isoform in the hypodermis could
substitute for the 5B isoform in mediating the essential function of
EGL-15, and whether expression of the 5B isoform in the SM could
replace the 5A isoform in mediating SM chemoattraction. Two
constructs, EGL-15(4A6) (expressing 5A) and EGL-15(4B6)(expressing
5B), were built that eliminate the alternative splicing of exon 5. These
constructs are predicted to express a single isoform in all places where
both EGL-15 isoforms are normally expressed. Immunoﬂuorescence
and western blot analysis of representative lines from each strain
conﬁrmed the expression of these constructs (Fig. S2).
As expected, the 4B6 transgene rescues viability in egl-15(null)
animals (5/5 lines). Interestingly, the 4A6 transgene rescues equally
well (7/7 lines). Thus, 5A can play the role that 5B normally playswhen
expressed where 5B is required for function. These data demonstrate
that tissue-speciﬁc expression is an important speciﬁcity factor for the
essential function. Moreover, the ability of both constructs to rescue
the essential function allowed us to observe the SM distributions in
these transgenic animals and the effects of either having only 5A or 5B
in the SMs. As expected, 4A6 animals display a normal SM distributionhypodermis, EGL-15(5A) is primarily expressed in the M lineage. (A,D,G) ayIs29[egl-15
als. α-GFP staining in ayIs6[Ptwist∷ GFP]-containing animals identiﬁes the SM and other
als. Staining in the syncytial hypodermis contrasts with the lack of staining in the seam
sgenic 5B, no expression is seen in the hypodermis (B). (D–F) EGL-15 expression in the
bsence of transgenic 5A, no expression is seen in the SM (F, I). (G–I) EGL-15 expression in
ed, α-EGL-15 (Pop) staining. Green, α-GFP staining. Scale bars, 10 μm.
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migration defects (Fig. 2C) despite being functional in the hypodermis
and expressed in the M lineage (Fig. S2A). These data indicate that
tissue-speciﬁc expression can account for only a portion of the
isoform-speciﬁc functions of EGL-15. Sequence-speciﬁc information
must be encoded by the 5A insert, since the 5A peptide is absolutely
required for normal SM positioning and cannot be replaced by the 5B
peptide to mediate SM chemoattraction.
In addition to these isoform-speciﬁc constructs, we also made a
construct, termed EGL-15(Δ5), that removes both the 5B and 5A
domains and creates a form of EGL-15 that resembles canonical FGFRs
that lack these domains. Transgenic animals with Δ5 arrays are viable
(5/5 lines), but have posteriorly-displaced SMs (Fig. 2D). Thus, similar
to 4B6, Δ5 can rescue the essential function but not the SM
chemoattraction function of EGL-15. Thus, in contrast to 5A, the 5B
insert is unlikely to encode speciﬁc information, since replacement of
the 5B insert with 5A sequence or completely removing the exon 5
peptide can restore viability to egl-15(null) animals.
EGL-15(5A) and EGL-15(5B) act in the sex myoblast to mediate opposing
mechanisms
To establish how SM migration is affected when SMs completely
lack EGL-15, we sought to eliminate all expression of EGL-15 in the
SMs. This required us to circumvent the EGL-15 requirement forFig. 2. Expression of EGL-15 isoforms lacking the 5A domain is not sufﬁcient to mediate
SM chemoattraction. All transgenes rescue the larval arrest phenotype of egl-15(n1456)
(A−B−). Transgenes with wild-type EGL-15 (NH#112, A+B+) (A), and EGL-15(4A6)
(NH#1159, expresses 5A) (B) restore SM chemoattraction. EGL-15(4B6) (NH#1160,
expresses 5B) transgenic animals have posteriorly displaced sex myoblasts (C). (D) EGL-
15(Δ5) cannot rescue the SM chemoattraction function.viability. Two experimental approaches were used to maintain EGL-15
expression speciﬁcally in the major hypodermis where it is necessary
for the essential function in an otherwise egl-15(null) mutant back-
ground: mosaic analysis and tissue-speciﬁc expression of egl-15 in the
hypodermis.
For the ﬁrst approach, we performed a mosaic analysis of egl-15
using an extrachromosomal array (ayEx86) containing both egl-15(+)
and the lineagemarker ncl-1(+) in an egl-15(null) background. Animals
remain viable due to having the array in a subset of cells that include
those necessary for viability, but can lose the array in the lineage
giving rise to the SMs, resulting in the complete loss of all EGL-15
isoforms in the migrating SMs. Mosaic animals that maintained the
array in the M lineage had precisely centered SMs (Fig. 3B). By
contrast, mosaic animals that lost the array in the M lineage had SMs
that were not precisely positioned, indicating a loss of the gonad-
dependent attraction (GDA; Fig. 3C). Thus, these results indicate that
EGL-15 is required in the migrating SMs for their chemoattractive
response. Mosaic losses in three particular animals speciﬁcally
implicate the SM as the necessary site of EGL-15. In these three
animals, one SM was non-Ncl, indicating that it maintained the array
and was EGL-15(+), while the other SM was Ncl, and thus had lost the
array and was EGL-15(−). In all three of these animals, the SMs that
contained the array were found correctly positioned at P6.p, while the
SMs that had lost the array were found at P6.pp, P7.p–P8.p, and P8.p.
Taken together, these results strongly indicate that EGL-15 is both
expressed and required in the SMs for chemoattraction to guide them
to their precise ﬁnal positions.
Interestingly, the centrally-dispersed distribution of SMs in the
mosaic animals (Fig. 3C) is signiﬁcantly different from the far posterior
positions typical of egl-15(A−B+) mutants (Fig. 3D). Although the ncl-1
(e1865)mutation has aminor effect on SMpositions (Fig. 3E), this does
not account for the different distributions. Thus, the loss of 5B in
addition to the loss of 5A alters SM migration guidance mechanisms,
implicating EGL-15(5B) in some aspect of this process as well. A simple
interpretation of these results that is consistent with the centrally-
dispersed SM distribution is that 5A is required for SM chemoattrac-
tion (the gonad-dependent attraction, or GDA) while 5B is necessary
for the gonad-dependent repulsion (GDR). In the absence of both
isoforms, the SMs are neither attracted nor repelled, resulting in the
centrally-dispersed distribution characteristic of animals lacking both
the GDA and the GDR (Branda and Stern, 2000).
By contrast to the abovemosaic results, a similar mosaic analysis in
a genetic background that instead retains the 5B isoform results in
repelled SMs. We conducted this analysis using the same ayEx86
extrachromosomal array in an egl-15(A−B+) background (Fig. 3F).
Similar to the results of the mosaic analysis in the egl-15(null)
background, mosaic animals that maintain the array in the M lineage
have precisely centered SMs (Fig. 3F, middle). Those that lose the array
in all scored lineages, including the M lineage, result in a posteriorly-
displaced distribution (Fig. 3F, top). Only a few mosaic animals were
found that lost the array speciﬁcally in theM lineage (since all animals
are viable in this background, there is no selection for animals that
maintain the array, making this class more difﬁcult to ﬁnd); the
positions of the SMs in these animals were consistent with a
posteriorly-displaced distribution (Fig. 3F, bottom). These results
conﬁrm that the presence of the 5B isoform can result in posteriorly-
displaced SM distributions.
As an alternative approach to observe the positions of SMs that lack
all EGL-15 expression, we created a set of integrated transgenic lines in
which EGL-15 was expressed tissue-speciﬁcally in the major hypo-
dermis using the Prol-6 promoter. In an egl-15(null) background, ex-
pression of EGL-15 from the Prol-6 promoter can rescue the essential
function of EGL-15, but leaves the SMs completely lacking EGL-15. The
advantage of this approach, as opposed to mosaic animals, was the
stability of the genotype; these arrays could be crossed into genetic
backgroundsexpressingthe5Bisoform[egl-15(A−B+)]ornot[egl-15(A−B−)]
Fig. 3. Complete loss of EGL-15 in the SMs is phenotypically different from loss of only EGL-15(5A). SM distributions in the following populations of animals. (A) Wild type. (B,C)
Mosaic animals derived from a strain homozygous for a null (5A−B−) allele of egl-15 that is viable due to an egl-15(+) transgene on an extrachromosomal array (genotype: ncl-1
(e1865); egl-15(n1456); ayEx86[egl-15(+)]). (B) Mosaic animals that retain the transgene in the SMs show normal SM chemoattraction, with centered SMs. (C) Mosaic animals that
have lost the transgene in the SMs and, thus, lack both EGL-15 5A and 5B. These SMs show a centrally-dispersed distribution. (D) egl-15(n1458) animals (A−B+) that lack EGL-15(5A),
resulting in posteriorly-displaced SMs. (E) ncl-1(e1865); egl-15(n1458), showing the effect of the ncl-1(e1865)mutation on SM positioning in an egl-15(n1458) (A−B+) background. (F)
SM distributions for subsets of the population of animals derived from the ncl-1(e1865); egl-15(n1458); ayEx86[egl-15(+)] mosaic progenitor strain. All progeny still express EGL-15
(5B) from the chromosomal egl-15(n1458) (A−B+) alleles. (F, top) Mosaic animals with broad losses of the transgenic array [ayEx86(−)]. SMs still have EGL-15(5B) and are posteriorly-
displaced. (F, middle) Mosaic animals that have maintained the wild-type egl-15(+) transgene in lineages that include the SMs [SM+]. SMs have both EGL-15 isoforms and are
centered. (F, bottom) Mosaic animals that have losses of the egl-15(+) transgene in a restricted number of lineages that include the SMs [SM−].
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to the GDR, the SM distribution should be shifted posteriorly in the
egl-15(A−B+) background. The stability of the genotype also would
allow gonad ablation to test whether the SMs were repelled by the
gonad.
SM distributions in these transgenic strains support a role for EGL-
15(5B) in the GDR. Extrachromosomal arrays that use the Prol-6
promoter to drive expression of EGL-15 in an egl-15(null) background
restore viability; SMdistributions in these lines are centrally-dispersed
(Fig. 4B), not posteriorly displaced. Arrays generated with other
promoters that drive EGL-15 expression in the hypodermis behaved
similarly (data not shown). The derived integrated lines also show
centrally-dispersed SMs (Figs. 4C–G), although to various extents:
ayIs30 is the most posterior distribution, with the others lying more
consistently intermediate between the mosaic distribution (Fig. 4A)
and the posterior positions typical of egl-15(A−B+) strains. Part of this
difference could be due to the slight anterior shift due to the ncl-1
(e1865)mutation present in the mosaic strain (see Fig. 3). Importantly,
all ﬁve of these distributions are displaced posteriorly when placed in
an egl-15(A−B+) background, consistent with the 5B isoform contribut-
ing to the GDR. SM distributions were determined for two of the
integrated transgenic lines in gonad-ablated, egl-15(A−B−) animals
(Figs. 4C, F). In these strains that lack all 5B in the SMs, SMdistributions
are shifted anteriorly, suggesting that the SMs in these transgenic lines
are still partially repelled by the gonad. However, the additional
repulsion observedwhen the 5B isoform is fully restored indicates that
robust SM repulsion requires the 5B isoform of EGL-15.
Discussion
Tissue-speciﬁc expression patterns determine signaling speciﬁcity for the
essential function, but the 5A insert is speciﬁcally required for SM
chemoattraction
FGF receptors are involved in a broad array of processes affecting
many aspects of vertebrate development and physiology (for reviewsee Ornitz and Itoh, 2001; Eswarakumar et al., 2005), and an
increasing number of roles are being found for the C. elegans FGF
receptor, EGL-15, as well (Huang and Stern, 2005). Here we have
investigated the mechanism of its roles in ﬂuid homeostasis and SM
migration. Previous work showed that the twomajor EGL-15 isoforms,
5A and 5B, are separately responsible for carrying out these twomajor
functions (Goodman et al., 2003). In addition, accumulating evidence
indicated that the tissue-speciﬁc expression of egl-15 mRNAs might
account for this functional speciﬁcity.
To understand the mechanistic basis of the functional speciﬁcity of
EGL-15 5A and 5B, we have looked directly at the cellular distribution
of these two EGL-15 isoforms. EGL-15 antibody staining shows that
the two major sites of EGL-15 expression are in the M lineage and the
major hypodermal syncytium. Transcriptional elements have been
identiﬁed in the Pegl-15 promoter that enable general expression in
both the hypodermis and the M lineage. The e15 enhancer region is an
important element for hypodermal expression (Huang and Stern,
2004), and ﬁve predicted binding sites for the mesodermal transcrip-
tion factor HLH-8/CeTwist (Harfe et al., 1998) appear to account for the
mesodermal expression of egl-15 in the M lineage: mutating these
sites can eliminate reporter gene expression in the M lineage and
compromise SM migration guidance (Branda, 2001).
In addition to transcriptional control of egl-15 expression, tissue-
speciﬁc alternative splicing controls which isoform is expressed at
each of these sites. Isoform-speciﬁc antibody staining experiments,
consistent with previously reported ﬁndings (Bulow et al., 2004;
Huang and Stern, 2004), demonstrate that expression of the 5A
isoform is normally conﬁned to the M lineage, including in the
migrating SMs, while the 5B isoform is predominantly expressed in
the hypodermis. Thus, evidence now solidly places the 5A isoform in
the migrating SMs, where mosaic analysis demonstrates it being
necessary for the gonad-dependent attractionmediated by the EGL-17
chemoattractant. The match between the 5A and 5B isoforms and the
sites at which they carry out their associated functions suggests that
regulation of tissue-speciﬁc alternative splicing could, in fact, account
for the normal functional speciﬁcities of these isoforms.
Fig. 4. Characterization of SMs lacking EGL-15 by expressing EGL-15 speciﬁcally in the
hypodermis. Prol-6∷ egl-15 transgenes express EGL-15 tissue-speciﬁcally in the
hypodermis. These transgenes can rescue the essential function of egl-15 without
expressing EGL-15 in the SMs. (A) Controls: egl-15(n484) (A−B+) animals without a
transgene; and the egl-15(n1456) mosaic animals from Fig. 3C. (B) Three independent
extrachromosomal arrays. (C–G) Integrated transgenes (ayIs30–33,36) in various
genetic backgrounds. These integrated lines are derived from line #1 in panel B. All
transgenes behave similarly, despite small differences in SM distributions. Expression in
an N2 background shows no observable SM migration defect. Expression in the egl-15
(n1456) (A−B−) background results in a broad distribution that is more anterior than that
of A−B+ strains, such as egl-15(n484). Expression in an egl-15(n484) (A−B+) background
results in the further posteriorization of this distribution. Gonad ablation in egl-15
(n1456) (A−B−) animals with Prol-6∷ egl-15 transgenes anteriorizes the distribution,
suggesting some residual repulsion in these strains.
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the primary regulator of functional speciﬁcity for the essential ﬂuid
homeostasis function, it does not account for the speciﬁcity of the 5A
isoform for SM migration guidance. While all forms of EGL-15,
including 5B, 5A and Δ5 (a form that mimics the architecture of other
FGFRs), can all mediate the essential ﬂuid homeostasis function of
EGL-15, only the 5A isoform can mediate SM chemoattraction. 5A is
also speciﬁcally required for other functions besides SM chemoattrac-
tion, such as CAN cell migration and axon position maintenance(Bulow et al., 2004; Fleming et al., 2005). Thus, structural differences
in the extracellular domains of the two EGL-15 isoforms are important
for their functional speciﬁcities, with the 5A isoform speciﬁcally
required for EGL-15 to serve as a chemoattractant receptor.
The separate sites of action for these two functions enabled us to
use a number of methods to observe the effect of complete loss of EGL-
15 function on the migrations of the SMs. Normally, severe loss of egl-
15 function causes animals to arrest development before SMmigration
occurs. By generatingmosaic animals that had lost all functional copies
of egl-15within the migrating SMs, we were able to conﬁrm that EGL-
15 acts cell-autonomously as the EGL-17 receptorwithin themigrating
SMs. EGL-15 has a similar cell autonomous role in CAN cell migration
(Fleming et al., 2005). Surprisingly, however, SM distributions in these
mosaic animals indicated that EGL-15 also contributes to the gonad-
dependent repulsion. Mosaic losses in the lineages giving rise to the
migrating SMs result in centrally-dispersed SMs, not the severely
posteriorly-displaced SMs characteristic of animals lacking only EGL-
15(5A). Thus, these data implicate EGL-15(5B) in SM chemorepulsion.
To conﬁrm the role of EGL-15 5B in chemorepulsion, we
expressed an egl-15(+) transgene under the control of a hypoder-
mal-speciﬁc promoter, establishing stable lines that lack EGL-15 in
the migrating SMs. The SMs in these animals also take on
centrally-dispersed ﬁnal positions. When the 5B isoform is
reintroduced into these lines, the SM distributions once again
resemble the severely posteriorly-displaced positions typical of
animals lacking only EGL-15(5A). Taken together, our data
demonstrate that 5B contributes to the gonad-dependent repulsion
by acting within the migrating SMs.
Both EGL-15(5A) and EGL-15(5B) function in the migrating sex myoblast
to mediate the gonad-dependent attraction and the gonad-dependent
repulsion, respectively
We propose a model in which the 5A and 5B isoforms both
function in the migrating sex myoblasts but trigger opposite
responses. The 5A isoform is clearly expressed in the migrating
SMs and can serve as the receptor for the EGL-17 chemoattractant.
EGL-17 expression in central cells of the somatic gonad (Branda and
Stern, 2000), reinforced by induced expression in the primary
vulval precursor cell directly ventral to the center of the gonad
(Burdine et al., 1998), both attracts the migrating SMs to their
precise ﬁnal positions and maintains their migrations along the
ventral muscle quadrants (Branda and Stern, 2000). In the absence
of 5A, a small amount of 5B expression in the SMs is necessary for
a gonad-dependent repulsion (GDR) of the SMs that otherwise are
moving anteriorly under the guidance of gonad-independent cues.
Although 5B is not normally expressed in the SMs at sufﬁcient
levels to permit observing it using the same approaches that allow
detection of the 5A isoform, traces of 5B expression have been
observed in the SMs of rare animals. More importantly, functional
evidence clearly implicates 5B in SM migration guidance, and the
mosaic analysis implicates it acting within the SM itself. The
distinction in the function of 5A and 5B in SM migration guidance
appears to be due to extracellular structural differences rather than
differences in expression level. For example, the 4B6 construct
expresses 5B at high levels in the M lineage and the SMs (Fig. S2A),
but results in repulsion, not attraction. It will be interesting to
understand how extracellular differences lead to different intracel-
lular responses.
SM chemorepulsion is only observed when the chemoattraction
mechanism is compromised, suggesting that a consequence of
activating the 5A-mediated chemoattraction is the inhibition of the
5B-mediated repulsion. Importantly, since both the attraction and the
repulsion require the same set of gonadal cells (Branda and Stern,
2000; Stern and Horvitz, 1991), this system of attraction and repulsion
does not appear to ﬁne-tune the ﬁnal positioning of the SMs by
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target cells.
While the 5A isoform acts as a receptor for an instructive
chemoattractive cue (Burdine et al., 1998), there is no evidence that
the 5B isoform acts instructively as the repellant receptor. The EGL-
17 FGF cannot be the repellant, since the repulsion is present even in
mutants lacking EGL-17 (Burdine et al., 1997; Goodman et al., 2003).
LET-756, the other C. elegans FGF (Roubin et al., 1999), appears to be
expressed fairly broadly in the body wall muscles, inconsistent with
it being localized in a way to allow it to function as a gonadal
repellant (Bulow et al., 2004). A model in which 5B acts permissively
in the GDR would allow a non-FGF ligand to be the actual repellant.
In such a case, activation of the 5B receptor would allow another
receptor to function as the chemorepellant receptor. To date, there is
no evidence suggesting the nature of such a chemorepulsion
receptor.
It is currently not known what accounts for the difference in the
function of the 5A and 5B isoforms, but many types of receptors for
migration cues play roles in both attractive and repulsive responses.
For example, netrins, ephrins, and semaphorins can all act as either
chemoattractants or chemorepellants during axon guidance (Cowan
et al., 2005; Culotti and Merz, 1998). In the case of netrins, the
different signaling response is dependent upon the presence or
absence of the UNC5 co-receptor (Baker et al., 2006; Hong et al., 1999;
Manitt and Kennedy, 2002). Similar to the netrins, the switch between
attraction and repulsion for the ephrins is also dependent upon the
presence or absence of other signaling molecules. In guiding axons
from retinal ganglion cells, ephrin binding stimulates the recruitment
of Vav2 to the intracellular domain of the Eph receptor. Endocytosis
due to transient activation triggers Eph signaling to switch from
attraction to repulsion (Cowan et al., 2005). Semaphorins can
alternatively stimulate the outgrowth of dendrites and repel growth
cones (Fenstermaker et al., 2004) depending upon the presence of
other molecules such as guanylate cyclases (Polleux et al., 2000),
neuropilin co-receptors (Wolman et al., 2004), and second messen-
gers such as cAMPs (Terman and Kolodkin, 2004).
Our data now place FGF receptors into this class of guidance
molecules that can trigger both attraction and repulsion. FGFs are
known to act both as attractants and repellants during vertebrate
neuronal development, but the mechanisms that mediate these
responses are not understood. For example, FGF8 acts as a
chemoattractant to guide trochlear axon growth (Irving and
Mason, 2000), while FGF2 stimulates retinal ganglional cell axon
extension and chemorepulsion (Weber et al., 1992). Continued
investigation of the mechanisms of EGL-15 signal transduction
should help shed light on how FGF receptors can mediate either
attraction or repulsion.
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